Bacteriocins inhibiting growth of vaginal lactobacilli

Information

  • Research Project
  • 6754761
  • ApplicationId
    6754761
  • Core Project Number
    R15AI054402
  • Full Project Number
    1R15AI054402-01A1
  • Serial Number
    54402
  • FOA Number
    PA-03-53
  • Sub Project Id
  • Project Start Date
    3/15/2004 - 21 years ago
  • Project End Date
    2/28/2008 - 17 years ago
  • Program Officer Name
    DEAL, CAROLYN D.
  • Budget Start Date
    3/15/2004 - 21 years ago
  • Budget End Date
    2/28/2008 - 17 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    3/15/2004 - 21 years ago
Organizations

Bacteriocins inhibiting growth of vaginal lactobacilli

[unreadable] DESCRIPTION (provided by applicant): Bacterial vaginosis (BV) is the leading cause of vaginal tract infection in women of reproductive age in the U.S. Evidence from epidemiological studies suggests that BV is a risk factor for serious female upper genital tract infections and preterm delivery, which is the major cause of perinatal morbidity and mortality in the developed world. The estimated cost to the U.S. of BV-related complications during pregnancy is $500 million to $1 billion, per annum. BV is a polymicrobial syndrome characterized by an alteration in the normal vaginal microflora, such that the Lactobacillus-dominated populations present in healthy individuals are replaced by Gardnerella vaginalis, anaerobes, and genital mycoplasmas. Currently, the mechanisms that cause this shift in the vaginal microflora are not well understood. Development of BV is generally preceded by decreased concentrations of lactobacilli; however, mechanisms which may account for the disappearance of the vaginal lactobacilli are not well documented. The overall goal of this study is to understand the pathogenesis of BV by describing microbial interactions that could lead to the decline in vaginal lactobacilli and pave the way for the establishment of a BV-associated microflora. Preliminary data collected with undergraduate student researchers in my laboratory show that certain strains of vaginal enterococci can produce a class of antibiotics known as bacteriocins, which inhibit the growth of vaginal lactobacilli in vitro. One objective of the proposed study is to chemically purify and characterize bacteriocins produced by vaginal enterococci. The in vivo significance of such antibacterial substances as a mechanism contributing to the decline of vaginal lactobacilli will be assessed using a chemostat to model the in vivo conditions of the vagina. In addition, chemical characterization of such bacteriocins may reveal novel antibacterial agents, with future potential for the control of microbial growth, including the treatment of infectious diseases. The involvement of undergraduate students in all aspects of this project will enhance the current strengths of our institution in engaging and mentoring students in the conduct and presentation of scientific research. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R15
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    188014
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIAID:188014\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    KALAMAZOO COLLEGE
  • Organization Department
    BIOLOGY
  • Organization DUNS
    062223532
  • Organization City
    KALAMAZOO
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    49006
  • Organization District
    UNITED STATES